Categories
· Health/Science
· Agricultural
· Business (General)
non-USA, by Country
· Israel
|
The company has developed human collagen from tobacco plants.
Jump to full article: Globes/Israel's Business Arena, 2006-09-04
Author: Gali Weinreb 4 Sep 06 16:04
Intro: CollPlant Ltd., which has developed human proteins from tobacco plants, has raised $1.5 million at a company value of $8 million before money. The round was led by a company that could become a future strategic partner, as well as Teva chairman Eli Hurvitz’s Pontifax Ltd.
Biomedix Incubator Ltd. (TASE:BMDX) subsidiary Meytav Technological Enterprises Innovation Center Ltd. owns 47.3% of CollPlant. Biomedix owns 75% of Meytav. Pontifax parter and Biomedix director Ran Nusbaum recently said that CollPlant was one of Biomedix’s most promising portfolio companies.
Jump to full article » |